Literature DB >> 7057372

Pharmacokinetic and biopharmaceutic parameters during enterohepatic circulation of drugs.

W A Colburn.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7057372     DOI： 10.1002/jps.2600710139

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  7 in total

1.  General treatment of the enterohepatic recirculation of drugs and its influence on the area under the plasma level curves, bioavailability, and clearance.

Authors:  J E Peris-Ribera; F Torres-Molina; M C Garcia-Carbonell; J C Aristorena; L Granero
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

2.  In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.

Authors:  Satish Sharan; Otito F Iwuchukwu; Daniel J Canney; Cheryl L Zimmerman; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

3.  A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorption.

Authors:  Y Plusquellec; G Campistron; S Staveris; J Barre; L Jung; J P Tillement; G Houin
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

4.  Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.

Authors:  F L Tse; F Ballard; J Skinn
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

5.  A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.

Authors:  Toshiya Moriwaki; Hiroyuki Yasui; Akira Yamamoto
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-04       Impact factor: 2.745

6.  Enterohepatic circulation of glucuronide metabolites of drugs in dog.

Authors:  Xin Zhou; Kenneth C Cassidy; Loyd Hudson; Michael A Mohutsky; Geri A Sawada; Junliang Hao
Journal:  Pharmacol Res Perspect       Date:  2019-07-04

7.  Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight.

Authors:  Christine Wegler; Luna Prieto Garcia; Signe Klinting; Ida Robertsen; Jacek R Wiśniewski; Jøran Hjelmesaeth; Anders Åsberg; Rasmus Jansson-Löfmark; Tommy B Andersson; Per Artursson
Journal:  Clin Pharmacol Ther       Date:  2020-10-18       Impact factor: 6.875
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.